Everus Construction (ECG) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $109.65, -1.80% vs the prior close of $111.66.
- Volume 1.11M shares, 2.4x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ECG dips 1.8% to $109.65, a 1-month low on 2.4x normal volume. Closed at $109.65, -1.80% vs the prior close of $111.66. Day range $107.12β$111.28, opened at $110.50.
ECG daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β ECG dips 1.8% to $109.65, a 1-month low on 2.4x normal volume
- Closed at $109.65, -1.80% vs the prior close of $111.66. Day range $107.12β$111.28, opened at $110.50.
- Volume was 1.11M shares, 2.4x its 50-day average of 464.15K β unusually heavy trading.
- Price is -9.5% vs its 50-day average ($121.15) and -12.3% vs its 200-day average ($125.09).
- 52-week range $78.14β$171.58; today's close sits at 34% of that range, 36.1% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 β ECG dips 1.8% to $111.66, 4 down days in a row
- Closed at $111.66, -1.77% vs the prior close of $113.67. Day range $103.49β$111.79, opened at $110.35.
- Volume was 586.90K shares, 1.2x its 50-day average of 479.00K.
- Price is -8.3% vs its 50-day average ($121.74) and -10.7% vs its 200-day average ($124.98).
- 52-week range $78.14β$171.58; today's close sits at 36% of that range, 34.9% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 β ECG slides 4.0% to $113.67, 3 down days in a row
- Closed at $113.67, -3.96% vs the prior close of $118.36. Day range $110.57β$116.72, opened at $114.88.
- Volume was 646.20K shares, 1.3x its 50-day average of 485.42K.
- Price is -7.1% vs its 50-day average ($122.33) and -9.0% vs its 200-day average ($124.86).
- 52-week range $78.14β$171.58; today's close sits at 38% of that range, 33.7% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 β ECG dips 1.4% to $118.36
- Closed at $118.36, -1.41% vs the prior close of $120.05. Day range $114.64β$120.48, opened at $117.44.
- Volume was 448.30K shares, 0.9x its 50-day average of 488.82K.
- Price is -3.6% vs its 50-day average ($122.78) and -5.1% vs its 200-day average ($124.74).
- 52-week range $78.14β$171.58; today's close sits at 43% of that range, 31.0% below the 52-week high.
Oct 12, 2026 β ECG dips 2.0% to $120.05
- Closed at $120.05, -1.95% vs the prior close of $122.44. Day range $119.53β$124.31, opened at $121.43.
- Volume was 414.30K shares, 0.8x its 50-day average of 496.14K.
- Price is -2.4% vs its 50-day average ($123.06) and -3.7% vs its 200-day average ($124.60).
- 52-week range $78.14β$171.58; today's close sits at 45% of that range, 30.0% below the 52-week high.
Oct 9, 2026 β ECG ends flat (+0.2%) to $122.44
- Closed at $122.44, +0.22% vs the prior close of $122.17. Day range $120.81β$124.81, opened at $124.81.
- Volume was 289.30K shares, 0.6x its 50-day average of 503.38K β lighter than usual.
- Price is -0.6% vs its 50-day average ($123.17) and -1.6% vs its 200-day average ($124.45).
- 52-week range $78.14β$171.58; today's close sits at 47% of that range, 28.6% below the 52-week high.
Oct 8, 2026 β ECG dips 2.5% to $122.17
- Closed at $122.17, -2.47% vs the prior close of $125.26. Day range $119.40β$124.98, opened at $123.30.
- Volume was 350.20K shares, 0.7x its 50-day average of 507.04K.
- Price is -0.8% vs its 50-day average ($123.18) and -1.7% vs its 200-day average ($124.29).
- 52-week range $78.14β$171.58; today's close sits at 47% of that range, 28.8% below the 52-week high.
Oct 7, 2026 β ECG slides 5.6% to $125.26
- Closed at $125.26, -5.64% vs the prior close of $132.74. Day range $122.33β$129.90, opened at $129.46.
- Volume was 482.70K shares, 1.0x its 50-day average of 507.09K.
- Price is +1.9% vs its 50-day average ($122.92) and +0.9% vs its 200-day average ($124.12).
- 52-week range $78.14β$171.58; today's close sits at 50% of that range, 27.0% below the 52-week high.
Oct 6, 2026 β ECG jumps 5.2% to $132.74, a 1-month high, 4 up days in a row
- Closed at $132.74, +5.21% vs the prior close of $126.17. Day range $128.09β$132.83, opened at $128.23.
- Volume was 415.80K shares, 0.8x its 50-day average of 505.89K.
- Price is +8.1% vs its 50-day average ($122.76) and +7.1% vs its 200-day average ($123.93).
- 52-week range $78.14β$171.58; today's close sits at 58% of that range, 22.6% below the 52-week high.
- That makes 4 straight gains.
Oct 5, 2026 β ECG rises 2.3% to $126.17, a 1-month high, 3 up days in a row
- Closed at $126.17, +2.29% vs the prior close of $123.35. Day range $120.91β$128.19, opened at $124.05.
- Volume was 614.50K shares, 1.2x its 50-day average of 502.50K.
- Price is +2.9% vs its 50-day average ($122.65) and +2.0% vs its 200-day average ($123.69).
- 52-week range $78.14β$171.58; today's close sits at 51% of that range, 26.5% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 β ECG jumps 3.1% to $123.35, a 1-month high
- Closed at $123.35, +3.11% vs the prior close of $119.63. Day range $121.64β$125.74, opened at $122.40.
- Volume was 415.40K shares, 0.8x its 50-day average of 500.90K.
- Price is +0.5% vs its 50-day average ($122.73) and -0.1% vs its 200-day average ($123.50).
- 52-week range $78.14β$171.58; today's close sits at 48% of that range, 28.1% below the 52-week high.
ECG latest news & SEC filings
Every SEC filing by or about ECG in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 8, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 2.03 β Took on a new material debt or financial obligation.
Sep 2, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Sep 1, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 1, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Sparby David M bought 1,000 shares at $144.95 (β$144.95K) on Aug 17, 2026
- Sparby David M bought 1,000 shares at $144.95 (β$144.95K) on Aug 17, 2026
- Sparby David M bought 1,000 shares at $144.95 (β$144.95K) on Aug 17, 2026
- Sparby David M bought 1,000 shares at $144.95 (β$144.95K) on Aug 17, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 11, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Sanderson Paul R. sold 3,300 shares at $136.69 (β$451.08K) on Aug 7, 2026
- Sanderson Paul R. sold 3,300 shares at $136.69 (β$451.08K) on Aug 7, 2026
- Sanderson Paul R. sold 3,300 shares at $136.69 (β$451.08K) on Aug 7, 2026
- Sanderson Paul R. sold 3,300 shares at $136.69 (β$451.08K) on Aug 7, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 7, 2026 Β· Form 144 β Planned insider sale
Notice of proposed sale (Form 144) β an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 5, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.23B (prior year $921.47M) (+33.7% vs Jun 30, 2025)
- Net income: $83.89M (prior year $52.84M) (+58.8% vs Jun 30, 2025)
- Diluted EPS: $1.64 (prior year $1.03) (+59.2% vs Jun 30, 2025)
Aug 4, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Jul 14, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 24, 2026 Β· Form 11-K β Annual report for an employee stock plan
Annual report for an employee stock plan
Things to know before you trade ECG
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 24, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 3, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.85% (largest 5.6%).
- Liquidity: about 444.09K shares (β$48.69M) trade per day on average.
- 52-week position: $109.65 vs a range of $78.14β$171.58 (34% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 4 sales; latest: David M Sparby bought 1,000 shares on Aug 17, 2026.
- Latest filings: 8-K Sep 8, 2026; 8-K Sep 2, 2026; 10-Q Aug 5, 2026.
- Share count: 51.06M shares outstanding (Aug 3, 2026), +0.1% vs a year earlier.
- Listing: NYSE Β· industry: Operative Builders.
ECG market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 110.50 | 111.28 | 107.12 | 109.65 | 1.11M |
| Oct 15, 2026 | 110.35 | 111.79 | 103.49 | 111.66 | 586.90K |
| Oct 14, 2026 | 114.88 | 116.72 | 110.57 | 113.67 | 646.20K |
| Oct 13, 2026 | 117.44 | 120.48 | 114.64 | 118.36 | 448.30K |
| Oct 12, 2026 | 121.43 | 124.31 | 119.53 | 120.05 | 414.30K |
| Oct 9, 2026 | 124.81 | 124.81 | 120.81 | 122.44 | 289.30K |
| Oct 8, 2026 | 123.30 | 124.98 | 119.40 | 122.17 | 350.20K |
| Oct 7, 2026 | 129.46 | 129.90 | 122.33 | 125.26 | 482.70K |
| Oct 6, 2026 | 128.23 | 132.83 | 128.09 | 132.74 | 415.80K |
| Oct 5, 2026 | 124.05 | 128.19 | 120.91 | 126.17 | 614.50K |
| Oct 2, 2026 | 122.40 | 125.74 | 121.64 | 123.35 | 415.40K |
| Oct 1, 2026 | 117.70 | 120.08 | 116.01 | 119.63 | 210.40K |
| Sep 30, 2026 | 118.17 | 118.74 | 116.27 | 117.52 | 359.90K |
| Sep 29, 2026 | 118.40 | 121.33 | 116.68 | 117.80 | 416.10K |
| Sep 28, 2026 | 116.71 | 119.40 | 114.35 | 116.66 | 315.30K |
| Sep 25, 2026 | 117.46 | 117.76 | 114.85 | 116.94 | 331.30K |
| Sep 24, 2026 | 112.75 | 116.96 | 112.36 | 116.70 | 431.50K |
| Sep 23, 2026 | 116.25 | 117.40 | 114.87 | 114.98 | 366.80K |
| Sep 22, 2026 | 116.75 | 117.80 | 114.37 | 116.27 | 308.90K |
| Sep 21, 2026 | 117.81 | 117.97 | 114.12 | 116.77 | 370.30K |
About Everus Construction
Everus Construction (ECG) is listed on the NYSE and classified by the SEC under βOperative Buildersβ. Its business address is in BISMARCK, ND. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 2015845.
ECG board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Rocca Michael Della | Director | May 13, 2026 |
| Helena Mercedes Hernandez | Director | May 13, 2026 |
| Dale Rosenthal | Director | Sep 1, 2026 |
| Edward A Ryan | Director | Sep 1, 2026 |
| David M Sparby | Director | Aug 18, 2026 |
| Jeffrey S Thiede | President & CEO | Mar 3, 2026 |
| Betty R. Wynn | Director | May 13, 2026 |
| Clark A. Wood | Director | May 13, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jason A. Behring | VP of Technology | Mar 3, 2026 |
| Britney A. Hendricks | VP of Human Resources | Mar 3, 2026 |
| Jon B. Hunke | VP & CAO | Mar 3, 2026 |
| Maximillian J Marcy | VP, CFO & Treasurer | Mar 3, 2026 |
| Thomas D. Nosbusch | EVP & COO | Mar 3, 2026 |
| Paul R. Sanderson | VP, CLO & Corporate Secretary | Aug 11, 2026 |
| Timothy Ryan Sznewajs | VP of Corp. Dev. & Strategy | May 26, 2026 |
| Jeffrey S Thiede | President & CEO | Mar 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 17, 2026 | David M Sparby | Buy | 1,000 | $144.95 |
| Aug 17, 2026 | David M Sparby | Buy | 1,000 | $144.95 |
| Aug 17, 2026 | David M Sparby | Buy | 1,000 | $144.95 |
| Aug 17, 2026 | David M Sparby | Buy | 1,000 | $144.95 |
| Aug 7, 2026 | Paul R. Sanderson | Sale | 3,300 | $136.69 |
| Aug 7, 2026 | Paul R. Sanderson | Sale | 3,300 | $136.69 |
| Aug 7, 2026 | Paul R. Sanderson | Sale | 3,300 | $136.69 |
| Aug 7, 2026 | Paul R. Sanderson | Sale | 3,300 | $136.69 |
| Dec 8, 2025 | Helena Mercedes Hernandez | Buy | 250 | $92.18 |
| Dec 8, 2025 | Helena Mercedes Hernandez | Buy | 250 | $92.18 |
| Dec 8, 2025 | Helena Mercedes Hernandez | Buy | 250 | $92.18 |
| Dec 8, 2025 | Helena Mercedes Hernandez | Buy | 250 | $92.18 |
ECG financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $3.75B | $201.77M | 3.95 | $156.84M |
| Dec 31, 2024 | $2.85B | $143.42M | 2.81 | $163.38M |
| Dec 31, 2023 | $2.85B | $137.23M | 2.69 | $171.34M |
| Dec 31, 2022 | $2.70B | $124.78M | 2.45 | $-25.50M |
Latest balance sheet: total assets $2.06B, total liabilities $1.28B, cash $553.00K (as of Jun 30, 2026).
ECG earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $136.16 |
| May 5, 2026 | 8-K Item 2.02 (results) | $168.32 |
| Feb 24, 2026 | 8-K Item 2.02 (results) | $104.21 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $86.63 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $75.80 |
| May 13, 2025 | 8-K Item 2.02 (results) | $51.42 |
| Feb 11, 2025 | 8-K Item 2.02 (results) | $68.42 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $54.61 |
Related stocks Β· Operative Builders
Horton D R (DHI)Nvr (NVR)Pultegroup (PHM)Toll Brothers (TOL)Kb Home (KBH)Meritage Homes (MTH)Beazer Homes Usa (BZH)M/I Homes (MHO)Green Brick Partners (GRBK)LGI Homes (LGIH)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ECG
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.